Anti-amyloid and other mechanisms continue moving through the Alzheimer's pipeline. Resolves YES if the FDA grants a new approval for an Alzheimer's disease therapy in calendar 2026. Source: FDA.
Market open
Jun 15, 2026, 03:26 p.m.
Market closes
Jan 8, 2027, 02:26 p.m.
Projected payout
After market closes
